1. Home
  2. NLSP vs VS Comparison

NLSP vs VS Comparison

Compare NLSP & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • VS
  • Stock Information
  • Founded
  • NLSP 2015
  • VS 2013
  • Country
  • NLSP Switzerland
  • VS United States
  • Employees
  • NLSP N/A
  • VS N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • VS EDP Services
  • Sector
  • NLSP Health Care
  • VS Technology
  • Exchange
  • NLSP Nasdaq
  • VS Nasdaq
  • Market Cap
  • NLSP 12.4M
  • VS 10.1M
  • IPO Year
  • NLSP 2021
  • VS N/A
  • Fundamental
  • Price
  • NLSP $2.13
  • VS $2.69
  • Analyst Decision
  • NLSP
  • VS Hold
  • Analyst Count
  • NLSP 0
  • VS 1
  • Target Price
  • NLSP N/A
  • VS $2.00
  • AVG Volume (30 Days)
  • NLSP 268.4K
  • VS 56.8K
  • Earning Date
  • NLSP 07-22-2025
  • VS 08-13-2025
  • Dividend Yield
  • NLSP N/A
  • VS N/A
  • EPS Growth
  • NLSP N/A
  • VS N/A
  • EPS
  • NLSP N/A
  • VS N/A
  • Revenue
  • NLSP N/A
  • VS $230,132.00
  • Revenue This Year
  • NLSP N/A
  • VS $3,459.21
  • Revenue Next Year
  • NLSP N/A
  • VS N/A
  • P/E Ratio
  • NLSP N/A
  • VS N/A
  • Revenue Growth
  • NLSP N/A
  • VS 64.71
  • 52 Week Low
  • NLSP $1.30
  • VS $1.00
  • 52 Week High
  • NLSP $15.59
  • VS $9.59
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 43.58
  • VS 57.23
  • Support Level
  • NLSP $2.20
  • VS $2.25
  • Resistance Level
  • NLSP $2.33
  • VS $2.78
  • Average True Range (ATR)
  • NLSP 0.25
  • VS 0.21
  • MACD
  • NLSP -0.07
  • VS 0.02
  • Stochastic Oscillator
  • NLSP 6.86
  • VS 73.07

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

Share on Social Networks: